PIGM and infection: When SARS-CoV-2 infects the respiratory tracts and lungs, mucosal immunity is expected to suppress infection establishment through the transcytosis and secretion of dIgA and pIgM across the lung epithelial cells by pIgR, together with other immune mechanisms [28].